n.血凝素

Hemagglutinin is a surface protein found on influenza viruses, which binds to red blood cells and aids in viral entry.
血凝素是流感病毒表面的一种蛋白质，它能与红血细胞结合，帮助病毒进入细胞。
The hemagglutinin mutation in the flu virus allows it to evade the host's immune system.
流感病毒中血凝素的变异使其能够避开宿主免疫系统的识别。
Researchers studied the structure of hemagglutinin to develop a more effective vaccine against the H5N1 strain.
研究人员研究了血凝素的结构，以研发针对H5N1型流感病毒的更有效疫苗。
Hemagglutinin plays a crucial role in the initial stage of influenza infection by facilitating attachment to host cells.
在流感感染的初期阶段，血凝素在帮助病毒附着到宿主细胞上起着关键作用。
The effectiveness of the antiviral treatment depends on its ability to inhibit the activity of hemagglutinin.
抗病毒治疗的效果取决于其抑制血凝素活性的能力。
The development of a universal flu vaccine focuses on targeting conserved regions of hemagglutinin to provide broader protection.
制备通用流感疫苗的目标是针对血凝素的保守区域，以提供更广泛的保护。
Hemagglutinin can be used as a diagnostic marker for detecting influenza infections in clinical samples.
血凝素可作为诊断标志物，用于检测临床样本中的流感病毒感染。
The high antigenic variability of hemagglutinin makes it challenging to create long-lasting immunity against influenza.
血凝素的高度抗原变异使得创建对流感持久免疫力变得困难。
Scientists are constantly monitoring the genetic changes in hemagglutinin to predict potential new flu strains.
科学家持续监控血凝素的基因变化，以预测可能的新流感株。
Influenza vaccines often target multiple hemagglutinin subtypes to protect against various strains of the virus.
流感疫苗通常针对多种血凝素亚型进行设计，以保护免受不同病毒株的侵袭。